TABLE 3

Difference in decline in forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) (mL·yr−1) and FEV1/FVC (%·yr−1) in men and women per sex-specific interquartile range increase in hormone level measured at baseline

Hormonal measureMenWomen
n=4333#n=4734#
FEV1 mL·yr−1FVC mL·yr−1FEV1/FVC %·yr−1FEV1 mL·yr−1FVC mL·yr−1FEV1/FVC %·yr−1
TT−0.91 (−2.66 to 0.84)−0.24 (−2.38 to 1.89)−0.02 (−0.04 to 0.00)0.98 (0.00 to 1.95)1.38 (0.18 to 2.59)0.00 (−0.01 to 0.01)
FAI1.04 (−0.39 to 2.47)1.46 (−0.28 to 3.20)0.01 (−0.01 to 0.03)0.77 (0.10 to 1.44)1.03 (0.20 to 1.86)0.00 (−0.01 to 0.01)
cFT0.76 (−0.82 to 2.34)1.55 (−0.37 to 3.47)−0.00 (−0.02 to 0.02)1.00 (0.12 to 1.89)1.45 (0.36 to 2.55)−0.00 (−0.01 to 0.01)
SHBG−2.69 (−4.44 to −0.95)−2.76 (−4.88 to −0.63)−0.03 (−0.05 to −0.01)−0.50 (−1.66 to 0.66)−0.77 (−2.20 to 0.66)−0.00 (−0.02 to 0.02)

All results are expressed in mL·yr−1 for average changes in FEV1 and FVC decline and %·yr−1 for FEV1/FVC ratio decline, with corresponding 95% CI. Linear mixed effects regression model adjusted for age, age2, standing height, body mass index, smoking status, pack-years, Townsend deprivation score, days per week of moderate physical activity, fresh fruit intake, time of appointment and a random intercept for participant. FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; TT: total testosterone;. FAI: free androgen index; cFT: calculated free testosterone; SHBG: sex hormone-binding globulin. #: numbers of participants with no covariates missing for the adjusted model. Bold text indicates a 95% CI not overlapping 0.